Physician profile
Alan D Heincker
NPI 1023304037
$2,861.64
in general payments reported to CMS, 2019-2025
13 companies · $14.10 in 2025
The $14.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.48 · 2020: $94.67 · 2021: $18.93 · 2022: $56.07 · 2023: $2,510 · 2024: $149 · 2025: $14.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,881 · Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,880.86 |
| Food and Beverage | $792.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,368.21 | 2023 | |
| Arthrex, INC. | $1,069.96 | 2023 | |
| Stryker Corporation | $190.26 | 2023-2024 | Blueprint Patient Specific Instrumentation |
| Pacira Therapeutics, INC. | $72.88 | 2020-2021 | |
| Smith+Nephew, INC. | $42.22 | 2020-2022 | |
| Bioventus LLC | $18.48 | 2019 | |
| Boston Scientific Corporation | $17.10 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.96 | 2023 | Iovera, Zilretta |
| Ebi, LLC | $14.10 | 2025 | Ebi Osteogen Implantable Bone Growth Stimulator |
| Eagle Pharmaceuticals, INC. | $14.00 | 2023 | |
| Pfizer INC. | $12.58 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.52 | 2022 | |
| Ferring Pharmaceuticals INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Heincker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.